Effects of Korean White Ginseng (Panax Ginseng C.A. Meyer) on Vascular and Glycemic Health in Type 2 Diabetes: Results of a Randomized, Double Blind, Placebo-controlled, Multiple-crossover, Acute Dose Escalation Trial

Esra' Shishtar; Elena Jovanovski; Alexandra Jenkins; Vladimir Vuksan

doi:10.7762/cnr.2014.3.2.89

Effects of Korean White Ginseng (Panax Ginseng C.A. Meyer) on Vascular and Glycemic Health in Type 2 Diabetes: Results of a Randomized, Double Blind, Placebo-controlled, Multiple-crossover, Acute Dose Escalation Trial

Clinical Nutrition Research ◽

10.7762/cnr.2014.3.2.89 ◽

2014 ◽

Vol 3 (2) ◽

pp. 89 ◽

Cited By ~ 17

Author(s):

Esra' Shishtar ◽

Elena Jovanovski ◽

Alexandra Jenkins ◽

Vladimir Vuksan

Keyword(s):

Type 2 Diabetes ◽

Panax Ginseng ◽

Dose Escalation ◽

Double Blind ◽

Double Blind Placebo ◽

Acute Dose ◽

White Ginseng ◽

Korean White Ginseng

Download Full-text

Review for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v2/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Decision letter for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

Diabetes Obesity and Metabolism ◽

10.1111/dom.13979 ◽

2020 ◽

Vol 22 (6) ◽

pp. 938-946 ◽

Cited By ~ 5

Author(s):

Juan Pablo Frias ◽

Michael A. Nauck ◽

Joanna Van ◽

Charles Benson ◽

Ross Bray ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulinotropic Peptide

Download Full-text

Review for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v1/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Decision letter for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v1/decision1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: Results of a randomized, double-blind, placebo-controlled study of efficacy and safety

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2006.04.003 ◽

2008 ◽

Vol 18 (1) ◽

pp. 46-56 ◽

Cited By ~ 170

Author(s):

Vladimir Vuksan ◽

Mi-Kyung Sung ◽

John L. Sievenpiper ◽

P. Mark Stavro ◽

Alexandra L. Jenkins ◽

...

Keyword(s):

Type 2 Diabetes ◽

Panax Ginseng ◽

Controlled Study ◽

Efficacy And Safety ◽

Red Ginseng ◽

Korean Red Ginseng ◽

Double Blind ◽

Double Blind Placebo ◽

Insulin Regulation

Download Full-text

Author response for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v2/response1 ◽

2020 ◽

Author(s):

Juan Pablo Frias ◽

Michael A Nauck ◽

Joanna Van ◽

Charles Benson ◽

Ross Bray ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Author Response ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Review for "Efficacy and Tolerability of Tirzepatide, a Dual GIP and GLP‐1 Receptor Agonist in Patients with Type 2 Diabetes: A 12‐Week, Randomised, Double‐Blind, Placebo‐Controlled Study to Evaluate Different Dose‐Escalation Regimens"

10.1111/dom.13979/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.735542506.793559665 ◽

2019 ◽

Author(s):

Carmine Zoccali ◽

Davide Bolignano

Keyword(s):

Type 2 Diabetes ◽

Chronic Kidney Disease ◽

Kidney Disease ◽

Glycaemic Control ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Lowering Effect

Download Full-text

Effects of vitamin D on serum levels and gene expression of enzymes aldose reductase, o-linked n-acetyl glucosamine transferase and glutamine fructose-6-phosphate aminotransferase in patients with type 2 diabetes: a randomized, double blind, placebo controlled clinical trial

International Journal of Food Properties ◽

10.1080/10942912.2021.1879131 ◽

2021 ◽

Vol 24 (1) ◽

pp. 337-345

Author(s):

Mahnaz Zarei ◽

Mohammad Hassan Javanbakht ◽

Hanieh Jafary ◽

Mahmoud Djalali

Keyword(s):

Gene Expression ◽

Type 2 Diabetes ◽

Clinical Trial ◽

Vitamin D ◽

Aldose Reductase ◽

Serum Levels ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text